A compound with the SMILES CCOCCCNc1nc2c(C)cccn2c(=O)c1/C=C1\SC(=S)N(C(C)CC)C1=O has a human ether-à-go-go related gene (hERG) inhibition at 1uM of 10.142\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
CCOCCCNc1nc2c(C)cccn2c(=O)c1/C=C1\SC(=S)N(C(C)CC)C1=O
CCOCCCNc1nc2c(C)cccn2c(=O)c1/C=C1\SC(=S)N(C(C)CC)C1=O
[C][C][O][C][C][C][N][C][N][=C][C][Branch1][C][C][=C][C][=C][N][Ring1][#Branch1][C][=Branch1][C][=O][C][=Ring1][N][/C][=C][\S][C][=Branch1][C][=S][N][Branch1][#Branch1][C][Branch1][C][C][C][C][C][Ring1][#Branch2][=O]
(5Z)-3-butan-2-yl-5-[[2-(3-ethoxypropylamino)-9-methyl-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one